Main content
Ideas Unbound
Contributing to the future of medicine through collaboration in drug discovery and regenerative medicine.
CONTACT USRICOH Technology
Driving Progress in Drug Discovery and Regenerative Medicine through the Synergy of Biotechnology and Digital Technologies.
Unlock the Power of Ricoh Group's Cutting-Edge Biomedical Technology in Your Research and Development
iPS cell technology
- The Custom Development of iPS-derived Cells
- AI-based high-content assay platform
- iPS-derived cell therapy
mRNA Technology (CDMO)
- Comprehensive mRNA Production Services Spanning from Research through Clinical Trials
- mRNA design consulting service
Bio 3D Printing Technology
- Specialized Production of Uniformly Encapsulated Cells
- Microphysiological System
- Micro Droplet Projection (MDP, fine granulation technology)
We are committed to pioneering breakthroughs in the fields of drug discovery and regenerative medicine.
CONTACT USNews
2024:
July 24,
Press release
Elixirgen Scientific and Mitsubishi Tanabe Pharma America Announce a Cell Supply Agreement for the Manufacturing of Human iPSC-Derived CNS Cell Types
2024:
July 12,
Press release
Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease
2024:
March 13,
Press release
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
2023:
October 10,
News topics
Exhibited at BioJapan 2023 [Japanese only]
2023:
March 27,
Press release
Ricoh made its first investment since the establishment of the "Ricoh Biomedical Startup Fund". [Japanese only]
2023:
March 23,
Press release
Successfully produced human neuronal cells useful for research on memory mechanisms and the development of therapeutic drugs for central nervous system disorders.
2022:
October 7,
Press release
The proposal by Ricoh and Elixirgen Scientific Japan was adopted for the Ministry of Economy, Trade and Industry's "Project for the Development of Biopharmaceutical Manufacturing Bases to Strengthen Vaccine Production Systems." [Japanese only]
2022:
October 5,
News topics
Exhibited at BioJapan [Japanese only]
2022:
August 30,
Press release
Established a fund to revitalize the mRNA drug discovery market in Japan.
News
The images shown are for illustrative purposes only.